πŸ‡ΊπŸ‡Έ FDA
Patent

US 8383817

Benztropine compounds and uses thereof

granted A61KA61K31/46A61K51/0455

Quick answer

US patent 8383817 (Benztropine compounds and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/46, A61K51/0455, A61P, A61P25/00